COMPLETED

Temporal Window and Episodic Future Thinking in CUD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective is to test the theory of Reinforcer Pathology via manipulation of the temporal window with successive Episodic Future Thinking generation in individuals with cocaine use disorder.

Official Title

Test Reinforcer Pathology Via Manipulation of the Temporal Window With Successive Episodic Future Thinking Generation.

Quick Facts

Study Start:2022-11-30
Study Completion:2025-11-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05507814

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. demonstrate recent cocaine use and CUD (use in last month, DSM-5 for CUD \> 4)
  2. 2. be 18 years of age or older
  3. 3. have a desire to quit or cut down on their cocaine use, but do not have proximate plans to enroll in treatment for CUD during the study period
  1. 1. meeting moderate to severe DSM-5 criteria for opioid use disorder
  2. 2. having a current diagnosis of any psychotic disorder
  3. 3. having a history of seizure disorders or traumatic brain injury
  4. 4. having any contraindication for participation in the MRI sessions

Contacts and Locations

Principal Investigator

Stephen LaConte, PhD
PRINCIPAL_INVESTIGATOR
Virginia Polytechnic and State University

Study Locations (Sites)

Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016
United States

Collaborators and Investigators

Sponsor: Virginia Polytechnic Institute and State University

  • Stephen LaConte, PhD, PRINCIPAL_INVESTIGATOR, Virginia Polytechnic and State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-30
Study Completion Date2025-11-24

Study Record Updates

Study Start Date2022-11-30
Study Completion Date2025-11-24

Terms related to this study

Additional Relevant MeSH Terms

  • Cocaine Use Disorder